<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:NCBITaxon="http://purl.obolibrary.org/obo/NCBITaxon#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br /> Synthesis, Analysis and Toxicity of Three Compounds <br /> Formed during the Synthesis of lodixanol <br />  <br />  <br />                                 Priebe, H., Dugstad, H., Heglund, I. F., Sande, R. and Tenseth, C. P., 1995. <br />                                 Synthesis, Analysis and Toxicity of Three Compounds Formed during the Syn- <br />                                 thesis of Iodixanol. - Acta Chern. Scand. 49: 737-743 &#169; Acta Chemica Scan- <br />                                 dinavica 1995. <br />                                 The origin of 4-acetyl-2-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6- <br />                                 triiodoanilinomethyl ]-5,7-diiodo-3,4-dihydro-2H-benzo[ 1,4]oxazine-6,8-dicarbox- <br />                                 ylic acid bis(2,3-dihydroxypropylamide):;:: N-acetyl cyclized iodixanol, 2-[N- <br />                                 acetyl-3,5-bis-(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilinomethyl]-5,7- <br />                                 diiodo-3,4-dihydro-2H-benzo[ 1,4]oxazine-6,8-dicarboxylic acid bis(2,3-dihydroxy- <br />                                 propylamide):::: cyclized iodixanol and 5,5&apos; -(N-acetyl-2-hydroxypropane-l,3- <br />                                 diyldiamino )bis[N,N&apos; -bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide] = <br />                                 deacetyl iodixanol in the manufacturing process of the X-ray contrast agent <br />                                 3,3&apos; ,5,5&apos; -tetrakis(2,3-dihydroxypropylcarbamoyl)-2,2&apos; ,4,4&apos; ,6,6&apos; -hexaiodo-N,N&apos; - <br />                                 (2-hydroxypropane-l,3-diyl)diacetanilide = iodixanol is discussed and their syn- <br />                                 thesis and purification are described. Their physical and toxicological properties, <br />                                 and analytical and spectroscopic <span id='am-34' about='obo:NCBITaxon_1369087' typeof='obo:NCBITaxon_37567 owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_37570 obo:NCBITaxon_41191 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_41196 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_95182 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_7100 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-35' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-37'  ></span><span id='am-38' property="rdfs:label" content="Data" datatype="xsd:string"></span>data</span> are summarized. <br />  <br />  <br />  <br /> X-Ray contrast agents generally contain heavy atoms                         nomethyl ]-5,7-diiodo-3,4-dihydro-2H-benzo[ 1,4]oxazine- <br /> such as iodine as an X-ray absorbent and hydrophilic                        6,8-dicarboxylic acid bis(2,3-dihydroxypropylamide). <br /> parts like carboxylic acid, carboxamide or hydroxy                             2 = Cyclized iodixanol = 2-[N-acetyl-3,5-bis(2,3-dihy- <br /> groups to achieve good water solubility. The type of hy-                    droxypropylcarbamoyl) - 2,4,6 - triiodoanilinomethyl] - 5,7- <br /> drophilic group classifies a tri-iodinated aromatic com-                    diiodo-3,4-dihydro-2H-benzo[ 1,4]oxazine-6,8-dicarboxy- <br /> pound as an ionic (1st generation) or non-ionic (2nd gen-                   lie acid bis(2,3-dihydroxypropylamide). <br /> eration) contrast agent. Third generation X-ray contrast                       3 = Deacetyl iodixanol = 5,5&apos; -(N-acetyl-2-hydroxyprop- <br /> agents such as iodixanol 1 are dimers of non-ionic tri-                     ane-1,3-diyldiamino )bis[N,N&apos; -bis(2,3-dihydroxypropyl)- <br /> iodinated aromatic compounds in a pharmaceutical for-                       2,4,6-triiodoisophthalamide]. <br /> mulation 2 which is isotonic 3 and isoosmotic 4 with blood.                    4 = Compound 5400 = 5-amino-N,N&apos; -bis(2,3-dihydro- <br />    In <span id='am-16' about='obo:NCBITaxon_order' typeof='owl:Thing NCBITaxon:_taxonomic_rank'><span id='am-17' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="order" datatype="xsd:string"></span>order</span> to avoid the presence of toxic components in                    xypropyl)-2,4,6-triiodo-isophthalamide. <br /> the iodixanol drug substance all impurities or degradation                     5 = TFA-allyl-5400 = 5-(N-allyl-2,2,2-trifluoroacetami- <br /> products above a certain concentration level are charac-                    do )-N,N&apos; -bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthal- <br /> terized by their origin, synthesis and analytical, spectro-                 amide. <br /> scopic and toxicological properties. N- Acetyl cyclized io-                    6 = Compound 5410 = 5-acetamido-N,N&apos; -bis-(2,3-di- <br /> dixanol 1, cyclized iodixanol 2 and deacetyl iodixanol 3                    hydroxypropyl)-2,4,6-triiodo-isophthalamide. <br /> are three representatives of possible impurities in the io-                    7 = TFA-5400-bromohydrin = 5-[N-(3-bromo-2-hydro- <br /> dixanol process. They may be formed during the synthe-                      xypropyl)-2,2,2-trifluoroacetamido ]-N,N&apos; -bis-(2,3- <br /> sis 5 or by degradation of iodixanol. Their molecular struc-                dihydroxypropyl)-2,4,6-triiodoisophthalamide. <br /> tures are summarized in Fig. 1.                                                8 = Iodixanol = 3,3&apos; ,5,5&apos; -tetrakis(2,3-dihydroxy- <br />    In <span id='am-6' about='obo:NCBITaxon_169495' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_169440 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_7147 obo:NCBITaxon_43733 obo:NCBITaxon_33154 obo:NCBITaxon_43738 obo:NCBITaxon_480117 obo:NCBITaxon_33317 obo:NCBITaxon_169449 obo:NCBITaxon_480118 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_43750 obo:NCBITaxon_33208 obo:NCBITaxon_85512 obo:NCBITaxon_197562 obo:NCBITaxon_197563 obo:NCBITaxon_7203 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_169455 obo:NCBITaxon_50557 obo:NCBITaxon_43741'><span id='am-7' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="This" datatype="xsd:string"></span><span id='am-10'  ></span>this</span> text molecule numbers and trivial names of their                 propylcarbamoyl)-2,2&apos; ,4,4&apos; ,6,6&apos; -hexaiodo-N,N&apos; -(2- <br /> abbreviations are used instead of the corresponding IV-                     hydroxypropane-1,3-diyl)diacetanilide. <br /> PAC names. 6 Their intercorrelation is given below.                            9 = Peracetyl cyclized iodixanol = acetic acid 2-acetoxy- <br />    1 = N-acetyl cyclized iodixanol = 4-acetyl-2-[N-acetyl-                  3- [3-{ acetyl-[ 4-acetyl-6,8-bis-(2,3-diacetoxypropyl- <br /> 3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanili-                   carbamoyl)-5,7-diiodo-3,4-dihydro-2H-benzo[ 1,4]oxazin- <br />                                                                             2-ylmethyl]amino}-5-(2,3-diacetoxypropylcarbamoyl)- <br />                                                                             2,4,6-triiodobenzoylamino ]propyl ester. <br />                                                                                10 = TFA-5400 = N,N&apos; -Bis(2,3-dihydroxypropyl)-2,4,6- <br /> t   To whom correspondence should be addressed.                             triiodo-5-(2,2,2-trifluoroacetamido)isophthalamide. <br />  <br />  <br /> Fig. 1. Molecular structures and numbering system of   13C   NMR carbon atoms of N-acetyl cyclized iodixanol 1, cyclized iodixanol <br /> 2 and deacetyl iodixanol 3. <br />  <br />  <br /> Origin and alternative synthesis                                    as an intermediate and was deacetylated under basic con- <br />                                                                     ditions in aqueous methanol to 1. <br /> Partial loss of acetic acid from iodixanol can generally <br /> occur under hydrolysis or solvolysis conditions to form <br /> deacetyl iodixanol 3. The synthesis of 3 is based on the            Acute intravenous toxicity <br /> ability of trifluoroacetamides to undergo solvolytic cleav- <br /> age more easily than the corresponding acetamide. The               Deacetyl iodixanol 3, N-acetyl cyclized iodixanol 1 and <br /> key step to 3 was the alkylation of 6 with TFA-5400-                cyclized iodixanol 2 were tested for acute toxicity in mice. <br /> bromohydrin 7 in basic aqueous medium. The bromo-                   The administration of 2 and 3 caused no effects on clini- <br /> hydrin 7 was prepared from 5 and bromine in aqueous                 cal signs and body weight development. Mortality and <br /> solution. 5 was prepared from compound 4 by acetylation             morbidity was seen in only three out of five mice to which <br /> with trifluoroacetic anhydride (TFAA) - 4-dimethyl-                 1 had been given. The mortality incidence of 3/5 at the <br /> aminopyridine (DMAP) followed by allylation with allyl              dose 14.7 gI kg - 1 of 1, is \vithin the lower range of the <br /> bromide (Fig. 2).                                                   ALD so (approximated median lethal dose) reported for <br />    N-Acetyl cyclized iodixanol 1 is formed when iodixanol           iodixanol of 15-18 gI kg- 1 in NMRI mice. s The lethal <br /> is exposed to basic conditions 7 at elevated temperatures           toxicity of 1 is probably similar or marginally higher than <br /> or at room temperature, e.g., when a solution of iodixanol          iodixanol. The doses of 3, 2 and 1 injected correspond to <br /> is left in contact too long with a strong basic ion exchange        about 500, 5000 and 15000 times the range of the speci- <br /> resin. Under the conditions of its formation 1 is mainly            fied amounts in a high clinical dose of 500 mgI kg - I <br /> deacetylated and forms cyclized iodixanol 2. This second            iodixanol. The presence of 1, 2 or 3 was therefore con- <br /> reaction strongly diminishes the remaining concentration            sidered to be of no significance for the toxicity of the <br /> of 1 and makes a different synthetic approach necessary.            clinical formulation 9 of iodixanol. <br />    2 was synthesized by the sequence shown in Fig. 3. <br /> The synthesis of 1 was based on the ability of acetates to <br /> undergo solvolytic cleavage more easily than the corre-             Experimental, material and methods <br /> sponding acetamides. 1 was synthesized from 2 by per- <br /> acetylation with acetic acid anhydride and p-toluene-               UV spectra were run on a Philips PU 8750 UVjVIS spec- <br /> sulfonic acid. Peracetyl cyclized iodixanol 9 was formed            trometer. IR spectra were measured on a Bruker IFS 66. <br />  <br />  <br /> Fig. 2. Preparation of deacetyl iodixanol 3. <br />  <br />  <br />  <br /> FAB-MS spectra were obtained with a V6 TRIO-2. All                       for 30 min and then a concave gradient from 10 to 50% <br /> NMR spectra were recorded at 25&#176;C on a Varian VXR-                       acetonitrile in water for 40 min (flow 1 ml min - I), To <br /> 300 S spectrometer with DMSO-d6 as the solvent and                       improve the detection limits and the quantification, the <br /> 1% vjv TMS as an internal reference. Chemical shifts are                 RP-18 method uses a &apos;high-low&apos; procedure 12 which com- <br /> reported as ranges when single resonances are split due                  bines data obtained with sample preparations with dif- <br /> to the presence of numerous rotational isomers 10 in so-                 ferent concentrations (2.5 mg ml- 1 and 25 mg ml- 1). The <br /> lution at 25 &#176;C. The chemical shift assignments to C-atom                amino column system utilised a Supelcosil LC-NH2, Su- <br /> numbers are valid only for the simulated BC NMR spec-                    pelco column (cat. No. 5-8338, 5 }Jm, 0.25 m long and <br /> tra 11 of the corresponding compounds. Elemental analy-                  4.6 mm in internal diameter). The chromatographic pa- <br /> ses were performed by lIse Beetz, Mikroanalytisches                      rameters were a linear gradient from 85-66 % acetonitrile <br /> Laboratorium, Postfach 1164, D-96301 Kronach, Ger-                       in water for 25 min (flow 2.5 rol min - 1). <br /> many. The preparative HPLC work was carried out on a <br /> Jobin Yvon Prepamatic LC - II by using a self-packed                     Acute intravenous toxicity. Male NMRI mice, weighing <br /> axial compression column with 80 mm ID, in reversed-                     20 &#177; 2 g were injected with a single dose of 3, 1 or 2 <br /> phase mode. The column was packed from a slurry con-                     intravenously in the tail at the rate of 1.2 ml min - 1. All <br /> taining isopropyl alcohol. The separation was monitored                  animals were fed a standard mouse diet (Ewos R3 pel- <br /> by refractive index coupled in series with a UV detector.                lets) and water ad libitum. 4-10 mice per group were <br /> The analytical HPLC was performed by using two meth-                     dosed according to Table 1. Clinical signs, body weight <br /> ods, an RP-18 column system and an amino-column sys-                     and mortality were registered over a period of 7 days. <br /> tem. Substances were detected with UV spectrophoto-                      Because of the low aqueous solubility 3 was formulated <br /> metric detection (254 nm). The RP-18 column system                       in DMSO (9.24%) to a final iodine concentration of <br /> utilised a Brownlee Labs column (cat. No. OD-5A, 5 }Jm,                  17 mgl ml- 1. The amount of DMSO given in the vehicle <br /> 0.25 m long and 4.6 mm in internal diameter). The chro-                  group was equivalent to the volumes given to the mice <br /> matographic parameters of the RP-18 HPLC method                          dosed with 3. 1 was formulated to a final concentration <br /> were a linear gradient from 3-10% acetonitrile in water                  of 300 mgl ml- 1 of which 87 % of the iodine content was <br />  <br />  <br /> Fig. 3. Decomposition of iodixanol 8 at high pH forming N-acetyl cyclized iodixanol 1 and cyclized iodixanol 2. <br />  <br />  <br />  <br /> Table 1. Dosages and mortality of mice after a single intra- <br /> venous injection of 1, 2 or 3; mortality is expressed as in-      Preparation of deacetyl iodixanol 3. <br /> cidence. <br />                                                                   Trifluoroacetylation oj 4. Trifluoroacetic anhydride <br />                                        Dose           Mortality <br /> Test substance                         (gl kg- 1 )    at day 7    (TFAA, 845 mmol, 177.5 g, 117.5 ml) and 4-N,N&apos;-di- <br />                                                                   methylaminopyridine (DMAP, 1.78 mmol, 200 mg) were <br /> Deacetyl iodixanol 3                   0.4            0/4         added to a suspension of 4 (141.8 mmol, 100 g) in toluene <br />                                        0.6            0/4         (500 ml) at 20-25 0 C. The reaction mixture was stirred at <br />                                        0.8            0/4         40 &#176; C. After 30 min all solid material was dissolved. Stir- <br />                                        1.0            0/4 <br />                                                                   ring at 40&#176;C was continued for 1 day. The mixture was <br /> N-acetyl cyclized iodixanol 1 (87%)    14.7           3/5         evaporated to dryness and redissolved in methanol-wa- <br /> Cyclized iodixanol 2                   5.4            0/10        ter (400 ml/40 ml). Activated carbon (5 g) was added and <br /> DMSO                                   0.50      ml   0/4         the mixture was stirred at 60-70 0 C for 30 min. The so- <br />                                        0.75      ml   1/4         lution was filtered cold and the filtrate was evaporated to <br />                                        1.00      ml   0/4         dryness. Yield: 106.7 g, 133.2 romol, 94% TFA-5400 10. <br />                                        1.20      ml   0/4 <br />                                                                   Allylation of 10. 10 (124.8 romol, 100 g) was dissolved in <br />                                                                   N,N&apos; -dimethylacetamide (DMA, 400 ml) and potassium <br /> 1. 2 was formulated to an iodine concentration of 50 mgI          carbonate (149.8 mmol, 20.7 g, 1.2 equiv.) was added. <br /> ml - 1. Because of the low solubility of 3 and 2, and the         Allyl bromide (149.8 mmol, 18.1 g, 12.6 ml, 1.2 equiv.) <br /> volume limits of 1.2 ml per 20 g mouse, 5.4 gI kg- 1 and          was added slowly to the reaction mixture. Stirring was <br /> 1.0 gI kg - 1, respectively was the maximum dose.                 continued at room temperature for 1 day. Additional allyl <br />  <br />  <br /> 740 <br />                                                                                                       IODIXANOL BY-PRODUCTS <br />  <br />  <br /> bromide (12.4 mmol, 1.5 g, 1.05 ml, 0.1 equiv.) was added      suspension was allowed to stand at room temperature <br /> and stirring was continued at room temperature for 1 day.      without stirring for 1 h and was filtered using a Millipore <br /> Acetic acid (8.6 mt) was added and the mixture was             filter. The filtrate was evaporated to dryness (50&#176; C/ <br /> evaporated to dryness under high vacuum. The residue           20 mbar) and the residue was dried in vacuo (50&#176;C/1 <br /> was dried at 50&#176;C in vacuo and suspended in water              day). Recovery: 24.5 g 3 (86.2%). <br /> (300 ml) with intensive stirring for 4-6 h. The white crys- <br /> talline substance formed was filtered off cold. The filter     Characterization and analysis of 3. <br /> cake was washed with cold water and dried (50&#176;CI               Isomerism. There is only one N-acetyl group that can form <br /> 50 mbar/l day). Yield: 88.1 g, 104.7 mmol, 84% TFA-            two exo/endo isomers 1o from restricted rotation about the <br /> allyl-5400 5, purity 83 %.                                     CO-N bond. One carbon atom in every side chain and <br />                                                                the central carbon atom in the bridge are chiral and form <br /> Hydroxybromination 015. 5 (11.9 mmol, 10.0 g) was <span id='am-11' about='obo:NCBITaxon_9822' typeof='owl:Thing obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_91561 obo:NCBITaxon_32523 obo:NCBITaxon_131567 obo:NCBITaxon_117570 obo:NCBITaxon_32524 obo:NCBITaxon_32525 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_33154 obo:NCBITaxon_1437010 obo:NCBITaxon_1338369 obo:NCBITaxon_40674 obo:NCBITaxon_8287 obo:NCBITaxon_314145 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_9821 obo:NCBITaxon_35497 obo:NCBITaxon_7776 obo:NCBITaxon_9347'><span id='am-12' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-13' property="rdfs:label" content="Sus" datatype="xsd:string"></span><span id='am-14'  ></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span>sus</span>-         32 RIS isomers. <br /> pended in water (1.1 1) at 50 &#176;C. The solution was cooled          HPLC. Achiral column material will not separate op- <br /> to O&#176;C. A solution of bromine (13.1 mmol, 2.1 g,               tical isomers resulting from chiral carbon atoms. The <br /> 1.1 equiv.) in water (200 ml) was added slowly over 2 h        resolution is usually to separate other types of rotamers <br /> during which the suspension almost dissolved. Amberlite        except exolendo isomers. The analytical HPLC (RP-18 <br /> <span id='am-1' about='obo:NCBITaxon_717364' typeof='owl:Thing obo:NCBITaxon_37567 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_85604 obo:NCBITaxon_104431 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_41191 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_6960 obo:NCBITaxon_33208 obo:NCBITaxon_82596 obo:NCBITaxon_82593 obo:NCBITaxon_197562 obo:NCBITaxon_41196 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_82592 obo:NCBITaxon_41197 obo:NCBITaxon_6656 obo:NCBITaxon_7496 obo:NCBITaxon_7088 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557'><span id='am-2' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-4'  ></span><span id='am-5' property="rdfs:label" content="Ira" datatype="xsd:string"></span>IRA</span>-68 ion exchange resin (20 ml) was added and stirred        column and amino column) shows two peaks due to <br /> at 0 &#176;C for 30 min. The ion exchange resin was filtered off    exo/endo isomerism with tR = 35.2 + 37.1 min and <br /> and the filtrate was freeze dried. Yield: 10.5 g, 11.2 mmol,   t R = 10.8 + 11.5 min, respectively. The purity was found <br /> 94 ~~ TFA-5400-bromohydrin 7.                                  to be 99.1 area % (RP-18 column) and 97.1 area % <br />                                                                (amino column). <br /> Alkylation 016 with 7. 6 (51.14 mmol, 38.2 g, 1.2 equiv.)          Elemental anal: Found: C25.85; H 2.83; N 5.83; I <br /> was dissolved in water (200 ml) at 50&#176;C pH 12.0. 7             50.77. Calc. for C33H4216N6014: C 26.28; H 2.81; N 5.57; <br /> (42.64 mmol, 40.0 g) was added slowly over 2 h. The pH         I 50.49. TLC: R(&apos;values are very similar to iodixanol on <br /> was kept constant at 12.0 for 2 days/room temperature.         silica and RP-18. On silica: methyl acetate-methanol- <br /> Some product precipitated. The reaction mixture was            acetic acid = 6:3: 1; R r = 0.5; ethyl acetate-methanol-ace- <br /> neutralized, evaporated to dryness, resuspended in             tic acid=6:3:1; R r =0.35; on RP-18 W/UV254 &apos;Mach- <br /> 400 ml 80% methanol, diluted with water to 50% metha-          erey-Nagel&apos; (cat. No. 811071): methanol-water = 2:8; <br /> nol and filtered. The filter cake was washed with 500 ml       R r = 0.6. M.p. 295-296&#176;C. IH NMR, 13C NMR. The ob- <br /> water and dried (16 g, 88 area % purity). The filtrate was     served IH and 13C NMR chemical shifts of 3 are sum- <br /> treated with IRA-68 and AMB-200 ion exchange resin             marized in Table 2 and Table 3, respectively. The results <br /> and the ion exchanger was filtered off. The filtrate 3 was     of the 13C NMR spectrum simulation of 3 are given in <br /> evaporated to drynes s (60 g, 61 % purity) and purified by     Table 3. UV: C= 0.949 x 10- 5 mol 1-1 (H 20); <br /> preparative HPLe.                                              Amax = 243 nm; E = 0.447; log &#163; = 4.652. IR13 (KBr): 3400, <br />                                                                3250 (s, N-H, O-H), 3100 (m, N-H), 2940, 2880 (m, <br /> Purification by preparative HPLC. 3 was ion exchanged by       C-H), 1640 (vs, C = 0 primary amide sidechains), 1550 <br /> using a mixed bed ion exchanger. The yield after ion ex- <br /> change was approx. 85 %. 99 grams were dissolved in <br />                                                                (s, C =    &#176;primary amide sidechains), 1400, 1280 (m, C5 <br />                                                                C-H), 1115, 1040 (m). Solubility in water: 10 g 1- 1; in <br /> 510 ml 20% methanol in RO water and filtered through           aqueous iodixanol (350 mg I/ml): 30 g 1- 1. FAB-MS: mlz <br /> a 0.45 Jlm filter before chromatography. Six repetitive        (% reI. int.) = 1509 (100, M + H); 1383 (65, M + 2H - I); <br /> cycles were run by injecting 16.5 g/85 ml on each cycle.       1257 (25, M + 3H - 21); 1129 (15, M + 2H - 31). <br /> Six fractions were taken and each worked up by vacuum <br /> evaporation. Fractions 3 and 4 (36.43 g) were 99.2% pure       Preparation olN-acetyl cyclized iodixanoll. A suspension <br /> 3 (stationary phase: Merck Lichroprep RP-18, 60 A, 25-         of 2 (3.0 g, MW 1379.77, 2.17 mmol) and p-toluene- <br /> 40 Jlm, 700 g, Vd = 1 1; mobile phase: solvent A = 20%         sulfonic acid (0.06 g, MW 172.22, 0.34 mmol) in acetic <br /> methanol in water; solvent B = 80% methanol in water; <br /> flow rate: approx. 85 ml min - 1; elution pressure: 7.6- <br /> 7.8 bar; cycle time: 80 min).                                  Table 2. 1 H NMR chemical shifts and assignments of 1, 2 <br />                                                                and 3 in DMSO-de . <br /> Final treatment for biological purpose. 3 (28.4 g, <br />                                                                Chemical         Chemical shift   Chemical shift   Chemical shift <br /> 18.8 mmol) was dissolved in water (2 I) at room tem-           group            of 1 (ppm)       of 2 (ppm)       of 3 (ppm) <br /> perature. Traces remained undissolved. Ion exchange <br /> resin IRA-68 (ca. 0.8 g) and IR-200 (ca. 0.8 g) were           CO-NH             8.8-8.0          8.8-7.9         8.7-8.0 <br /> added until the pH remained stable at 6.5. Activated <span id='am-24' about='obo:NCBITaxon_201850' typeof='owl:Thing obo:NCBITaxon_1125798 obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_71529 obo:NCBITaxon_41084 obo:NCBITaxon_33154 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_41088 obo:NCBITaxon_7496 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_7041'><span id='am-25' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-26' property="rdfs:label" content="Car" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-28'  ></span>car</span>-      Ar-NH                              5.4-5.2         5.1 <br />                                                                OH                4.9-4.4          4.9-4.4         4.9-4.4 <br /> bon (ca. 0.5 g) was added to the solution and stirred at       CH, CH 2          4.3-2.7          4.3-2.9         4.4-2.8 <br /> room temperature for 1 h. The suspension was filtered          CO-CH 3 (endo)   2.34-2.02        2.28-2.24        2.25 <br /> using a Millipore filter. Neutral aluminium oxide (grain       CO-CH 3 (ring)   2.34-2.02 <br />                                                                CO-CH 3 (exo)    1.88-1.72        1.85-1.77        1.78 <br /> size 50-200 Jlm, ca. 0.5 g) was added to the filtrate. The <br />  <br />                                                                                                                             741 <br />  PRIEBE ET AL. <br />  <br />  <br /> Table 3. 13C NMR chemical shifts and assignments of             Table 4. 13C NMR chemical shifts and assignments of <br /> deacetyl iodixanol 3 in DMSQ-d6 .                               N-acetyl cyclized iodixanol 1 in DMSQ-d6 . <br /> Chemical shift      Simulation 11      Assignment to            Chemical shift      Simulation 11      Assignment to <br /> of 3 (ppm)          (ppm)              C-atom No. in Fig.       of 1 (ppm)          (ppm)              C-atom No. in Fig. <br />  <br /> 170.2-170.1         171.4&#177;2.9          16                       170.7-168.7         171.4&#177;2.9          20 <br /> 169.8-169.4         170.7 &#177; 1.7        4 11 26 30               170.7-168.7         170.7&#177;1.7          11 32 28 <br /> 149.8               149.9&#177;             20                       170.7-168.7         169.6&#177;0.2          16 <br /> 15 1.4-1 50.5       150.0&#177;3.1          5 9 22 24                166.2-165.7         166.1 &#177;0.5         4 <br /> 147.8-147.4         147.6&#177;1.8          7                        151.3-150.7         150.0&#177;3.1          926 24 <br /> 101.3-99.5           98.6&#177;4.4          68                       147.5-146.6 <br />  92.3-91.5           98.6&#177;4.4          21 25                    144.7               147.6&#177; 1.8         22 <br />  83.3-82.9           89.9&#177;2.9          1023                     142.0-14 1.4        142.411.7          6 <br />  70.0-69.7           70.4&#177;0.7          2132832                  133.1               132.5&#177;3.4          5 <br />  68.4-68.0           69.7&#177;             18                       130.5-130.0         130.2&#177;0.5          7 <br />  63.8-63.7           64.3&#177;0.6          1 14 29 33               100.5-99.0           98.6&#177;4.4          2327 <br />  54.9-54.2           53.4&#177;             17                        96.5-95.6 <br />  53.6-53.3           50.0t             19                        92.2-91.9           89.9&#177;2.9          25 <br />  42.4-42.2           43.0tO.6          3122731                   90.7-90.4           89.0&#177;6.8          8 <br />  22.7-22.1           22.9tO.7          15                        89.4                82.317.6          10 <br />                                                                  77.7-76.7           77.4&#177;0.2          18 <br />                                                                  70.7-69.6           70.4&#177;0.7          2 13 30 34 <br />                                                                  63.8-63.4           64.3&#177;0.6          1143135 <br /> acid anhydride (15 ml) was heated to 70&#176;C. Within 3 h            52.2-51.4           51.9&#177;0.0          19 <br />                                                                  44.5-43.9           45.4&#177;0.0          17 <br /> the reaction mixture became a homogeneous solution of            42.5-41.9           43.0&#177;0.6          3122933 <br /> 9. The solution was evaporated to dryness and redis-             23.7; 22.4          22.910.7          15 21 <br /> solved in methanol-\vater (80:20~ 15 ml). In order to <br /> deacetylate only O-acetyl groups the pH of the solution <br /> was adjusted to 11.5. After 3 h of stirring at room tem- <br /> perature the solution was neutralized and evaporated to         C3sH431sN601S: C 29.56; H 3.05; N 5.91; 1 44.61. TLC: <br /> dryness. The crude 1 (3.5 g) was purified by preparative        TLC system on silica: chloroform-methanol-acetic <br /> HPLC.                                                           acid = 50:50:2; R r: 0.52. M.p. 234-236&#176;C. IH NMR, l3C <br />                                                                 NMR: the observed 1Hand l3C NMR chemical shifts of <br /> Purification by preparative HPLC. 1 (101.25 g) was dis-         1 are summarized in Table 2 and Table 4, respectively. <br /> solved in 380 ml 18 % methanol in RO-water and filtered         The results of the 13C NMR spectrum simulation of 1 are <br /> through a 0.45 Jlm filter before chromatography. Four re-       given in Table 4. UV: C= 1.077 x 10- s mol 1-1 (H 2 0); <br /> petitive cycles were run by injecting 25.3 g/95 ml each         Amax = 240 nm; E = 0.610; log E = 4.753. IR (KBr): 3360, <br /> cycle. Six fractions were taken and each was worked up          3250 (s, N-H, O-H), 3080 (m, N-H); 2930, 2880 (m, <br /> by vacuum evaporation. Based on total area % of an              C-H), 1745, 1700 (s, C = 0 N-acetyl), 1640 (vs, C = 0 <br /> analytical HPLC chromatogram on RP-18, the fractions <br /> 3, 4 and 5 (22 g) were&gt; 98.5 % pure (stationary phase: <br />                                                                                                             &#176; <br />                                                                 primary amide sidechains), 1570 (s, C = primary amide <br />                                                                 sidechains); 1370, 1390 (s, (5 C-H acetyl); 1030, 1050 <br /> Merck Lichroprep RP-18, 60 A, 25-40 Jlm; mobile                 (m). FAB-MS: m/z (% reI. int.) = 1423 (100, M + H); <br /> phase: solvent A = 21 % methanol in water; solvent              1297 (70, M + 2H - I); 1171 (38, M + 3H - 21); 1042 (20, <br /> B = 80% methanol in water; flow rate: approx. 85 ml             M + H - 31). <br /> min -1; elution pressure: 8.9-9.1 bar; cycle time: 80 min). <br />                                                                 Preparation of cyclized iodixanol 2. lodixanol 8 (110 g, <br /> Characterization and analysis oj 1.                             71 mmol) was dissolved in a solution of sodium hydrox- <br /> Isomerism. The rotation of the N-acetyl group connected         ide (35.6 g, 0.89 mol) in water (3.2 1). The solution was <br /> to the oxazine ring is fixed. However, the other N-acetyl       heated to 75 &#176;C for 20 h. The mixture was neutralized <br /> group can form 2 exo/endo isomers 10 from restricted ro-        with cone. HCI and the solvent was removed under re- <br /> tation about the CO-N bond. One carbon atom in every            duced pressure. The residue was dissolved in methanol <br /> side chain and position 2 of the benzoxazine ring are           (1. 3 1) at 50 &#176;C. The solution was cooled to 0 &#176;C and <br /> chiral and the structure forms 32 R/S isomers.                  precipitated salts were removed by filtration. The filtrate <br />       HPLC. The resolution is usually insufficient to sep-      was treated with active carbon at 40-50 &#176;C for 1.5 h be- <br /> arate other types of rotamer except exo/endo isomers. The       fore further filtration. The filtrate was evaporated to dry- <br /> analytical HPLC (RP-18 column and amino column)                 ness and gave crude 2 (96.7 g, 88.3 % purity, 87 % yield). <br /> shows two peaks due to exo/endo isomerism with <br /> t R = 35.5 + 43.1 min and t R = 8.7 + 11.0 min, respectively.   Purification by preparative HPLC. 2 (127 g) was dissolved <br /> The purity was found to be 99.4 area % (RP-18 column)           in 500 ml 21 % methanol in water and filtered through a <br /> and 99.1 area % (amino column). Elemental anal:                 0.45 nm filter before chromatography. Five repetitive <br /> Found: C29.27; H 3.08; N 6.08; 1 44.68. Calc. for               cycles were run by injecting approx. 25.4 g/100 ml each <br />  <br />  <br /> 742 <br />                                                                                                        IODIXANOL BY-PRODUCTS <br />  <br />  <br /> cycle. Eight fractions were taken and fractions 2-8 were       Table 5. 13C NMR chemical shifts and assignments of cy- <br /> worked up by vacuum evaporation. Based on total area           c1ized iodixanol 2 in DMSO-d6 . <br /> % of an analytical HPLC chromatogram on RP-18 the              Chemical shift         Simulation 11     Assignment to <br /> fractions 3-6 (20.3 g) were &gt; 99.1 % pure (stationary          of 2 (ppm)             (ppm)             C-atom No. in Fig. <br /> phase: Merck Lichroprep RP-18, 60 A, 25-40 J.!m, 700 <br /> gram, V.d. = 11; mobile phase: solvent A = 21 % methanol       <br /> in water, solvent B = 80% methanol in water; flow rate:     <br /> approx. 86 ml min - 1; elution pressure: approx. 11 bar;        <br /> detection: RI sens. 8, UV out of function; cycle time:        <br /> 75 min).                                               <br /> Characterization and analysis oj 2.                            <br /> Isomerism. The N-acetyl group can form 2 exo/endo <span id='am-29' about='obo:NCBITaxon_238707' typeof='owl:Thing obo:NCBITaxon_186623 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_186625 obo:NCBITaxon_117570 obo:NCBITaxon_89593 obo:NCBITaxon_7742 obo:NCBITaxon_117571 obo:NCBITaxon_123369 obo:NCBITaxon_33154 obo:NCBITaxon_1489908 obo:NCBITaxon_123367 obo:NCBITaxon_123368 obo:NCBITaxon_123365 obo:NCBITaxon_123366 obo:NCBITaxon_1489872 obo:NCBITaxon_2759 obo:NCBITaxon_6072 obo:NCBITaxon_33511 obo:NCBITaxon_33208 obo:NCBITaxon_7711 obo:NCBITaxon_1489388 obo:NCBITaxon_1489341 obo:NCBITaxon_7776 obo:NCBITaxon_1489913 obo:NCBITaxon_8075 obo:NCBITaxon_7898 obo:NCBITaxon_32443 obo:NCBITaxon_41665 obo:NCBITaxon_1489917'><span id='am-30' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-32'  ></span><span id='am-33' property="rdfs:label" content="Iso" datatype="xsd:string"></span>iso</span>-       <br /> mers 10 from restricted rotation about the CO-N bond.          <br /> One carbon atom in every side chain and position 2 of the   <br /> benzoxazine ring are chiral and 32 R/ S isomers are             <br /> formed.                                                         <br />    HPLC. Since the resolution is insufficient to separate    <br /> syn/anti and <span id='am-19' about='obo:NCBITaxon_245896' typeof='owl:Thing obo:NCBITaxon_33340 obo:NCBITaxon_33213 obo:NCBITaxon_1 obo:NCBITaxon_131567 obo:NCBITaxon_71527 obo:NCBITaxon_41084 obo:NCBITaxon_33154 obo:NCBITaxon_219428 obo:NCBITaxon_33317 obo:NCBITaxon_2759 obo:NCBITaxon_6960 obo:NCBITaxon_6072 obo:NCBITaxon_33208 obo:NCBITaxon_197562 obo:NCBITaxon_85512 obo:NCBITaxon_197563 obo:NCBITaxon_6656 obo:NCBITaxon_41088 obo:NCBITaxon_7496 obo:NCBITaxon_577181 obo:NCBITaxon_1206794 obo:NCBITaxon_88770 obo:NCBITaxon_33392 obo:NCBITaxon_50557 obo:NCBITaxon_7041'><span id='am-20' property="rdfs:label" content="Cis" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="ncbi_taxonomy" datatype="xsd:string"></span><span id='am-22'  ></span><span id='am-23' property="oboInOwl:hasDbXref" content="GC_ID:1" datatype="xsd:string"></span>cis</span>/trans isomers we expect only two isomers      <br /> to be separated. The analytical HPLC (RP-18 column          <br /> and amino column) shows three peaks most probably due          <br /> to exo/endo isomerism with tR = 27.9 + 34.4 + 35.0 min         <br /> and t R = 9.6 + 12.7 + 14.9 min, respectively. Isomerisation <br /> studies showed that the three peaks all belong to the <br /> product. The purity was found to be 99.5 area % (RP-18 <br /> column) and 99.5 area % (amino column). Elemental <br />                                                                 <br /> anal: Found: C 28.81; H 3.14; N 5.74; I 45.92. Calc. for <br /> C33H41IsN6014: C 28.72; H 2.99; N 6.09; I 45.97. TLC:          <br /> TLC system on silica: chloroform-methanal-acetic             <br /> acid = 50:50:5; two spots with R r: 0.52 and 0.29. Solu-        <br /> bility: in water: &quot;&quot; 2 mg ml- I measured by TLC. At- <br />                                                              <br /> tempts to make a solution of 2 mgI ml- I (4.3 mg ml- 1)        <br /> in water failed. Attempts to make a solution of 20 mgI        <br /> ml- I (43 mg ml- 1) in methanol failed. M.p. 225-230 o e.       <br /> IH NMR, l3C NMR. The observed 1H and l3e NMR                   <br /> chemical shifts of 2 are summarized in Table 2 and              <br /> Table 5, respectively. The results of the 13C NMR spec-        <br /> trum simulation of 2 are given in Table 5. UV:             <br /> C=I.811xlO-&#183; s mol 1-1 (H 2 0); Amax =234 nrn;                 <br /> E = 1.036; log E = 4.769. IR diffuse reflectance measure-   <br /> ment of 1.99% 2 in KBr: 3360, 3230 (m, N-H, O-H),              <br /> 3070 (m, N-H), 2935, 2880 (w, C-H), 1653, 1630 (vs,       <br /> C = 0 primary amide sidechains), 1570 (s, C = 0 primary      <br /> amide sidechains); 1435, 1390 (s, 8 C-H acetyl), 1036              <br /> (m). FAB-MS: nl/z (% reI. int.) = 1403 (50, M + Na),              <br /> 1381 (100, M + H), 1277 (25, M + H + Na - I); 1255 (49,         <br /> M + 2H - I); 1129 (10, M + 3H - 21).                               <br />   <br /> </body></html>